Trends

Breast cancer

Medicine & Biotech · covered by 56 outlets this week · tracked since 2026-10-27

Press: 39 mainstream 105 specialist 60 independent outlet-days

What it is

Breast cancer is the most common cancer in women worldwide and one of the most studied, with survival above 90 percent at five years when found early in high-income countries. Treatment is now sorted by subtype (hormone-receptor, HER2, triple-negative), and the active fronts are avoiding chemotherapy when genomic tests say it is safe, antibody-drug conjugates for advanced disease, screening intervals and density, and inherited risk. Most lumps investigated turn out to be benign.

Written by the Alivewire editors from the coverage below, 3d ago. Not medical advice; how the ratings work.

Coverage